Clinical governance

Purpose

Clinical governance is how we make sure that the care provided at Heal & Go₂ Medical is safe, evidence-based, appropriately delivered and continually reviewed.

This page explains who holds clinical responsibility, how our clinical standards are maintained, how medical information published on this website is approved, and how we review and improve the quality and safety of our service.

Every condition page on this website links back to this page, because the clinical claims we make are only as reliable as the evidence and the governance processes behind them.

Who is clinically responsible

Clinical responsibility for the medical services and medical content provided by Heal & Go₂ Medical is led by our Medical Director, Dr Anil Dasineni.

As Medical Director he provides clinical leadership and oversight of clinical governance, patient safety and standards of hyperbaric practice. His responsibilities include oversight of clinical policies and treatment protocols, standards of patient assessment and selection, clinical prescribing, and the clinical accuracy of medical information published by Heal & Go₂ Medical.

Clinical information on this website is provided for general information. It does not replace an individual medical assessment, or advice from a clinician responsible for your care.

Named people and credentials

Dr Anil Dasineni
Medical Director and Hyperbaric Physician
MBBS, DNB (Emergency Medicine), MRCEM
GMC registered with a licence to practise

Hyperbaric and further training: Basic Hyperbaric Medicine Course, DDRC Healthcare · Hyperbaric Chamber Operator Course, DDRC Healthcare · Diploma in Remote and Offshore Medicine (DipROM), Royal College of Surgeons of Edinburgh

Our regulatory position

Heal & Go₂ Medical operates a CQC-aligned clinical governance framework.

How our clinical care is governed

Hyperbaric oxygen therapy at Heal & Go₂ Medical is delivered within approved clinical policies, procedures and treatment protocols.

These govern:

• patient assessment and selection
• indications and contraindications for treatment
• individual prescribing of hyperbaric oxygen therapy
• informed consent
• treatment delivery and patient monitoring
• clinical escalation and emergency procedures
• medicines management
• infection prevention and control
• safeguarding
• staff training and competency
• documentation and clinical record keeping

Our protocols require a medical assessment before hyperbaric oxygen therapy is prescribed. Treatment pressure, duration and number of sessions are determined by the relevant clinical indication, the approved treatment protocol, and the patient's individual clinical circumstances.

Treatment is not selected or prescribed by the patient.

You can read more about who is and is not suitable for treatment on our [safety page](/safety).

Quality and patient safety

Clinical quality and safety are monitored through our governance processes. These include clinical audit, incident and near-miss reporting, complaints and patient feedback, review of clinical outcomes, staff training and competency assessment, and periodic review of clinical policies and treatment protocols.

Where an incident, complaint, audit finding, new evidence or regulatory development identifies an opportunity to improve care, it is reviewed through the appropriate governance process. Actions arising from those reviews are recorded and followed through to completion.

Our aim is not simply to hold policies, but to use governance actively to identify risks, learn from experience, and improve the safety and quality of care.

Evidence and clinical claims

Hyperbaric oxygen therapy has a well-established evidence base for a defined set of conditions, and a far less certain one for many others. We think the difference matters, and we try to make it visible rather than blur it.

When we describe what HBOT can do for a given condition, we work from published clinical guidance and the accepted indication lists, including guidance from the National Institute for Health and Care Excellence, the Undersea and Hyperbaric Medical Society, and the European Committee for Hyperbaric Medicine.

Where UK guidance is cautious or negative about HBOT for a condition, we say so on the page for that condition, including where that guidance runs against our own commercial interest.

Where evidence is uncertain, limited or still emerging, our clinical information says that plainly rather than presenting it as settled.

The decision to offer HBOT to an individual patient is separate from the decision to publish information about a condition on this website. Being able to read about a condition here does not mean HBOT will be appropriate for you. Treatment is offered only following medical assessment, and only where it falls within the scope of the service and its approved clinical framework.

How medical information on this website is approved

Every clinical page on this website is reviewed and approved before publication.

A clinical page begins as a draft. While in draft it is marked noindex, excluded from the website sitemap, and absent from normal site navigation. It is not intended to be publicly discoverable, and search engines are instructed not to index it.

The page is then reviewed through a private, page-specific review process. Two separate approvals are required.

Clinical approval considers whether the medical content is accurate, appropriately evidenced, and consistent with Heal & Go₂ Medical's approved clinical framework.

Advertising approval considers whether the wording, claims and presentation are appropriate to the strength of the supporting evidence, and to applicable advertising requirements.

These approvals are deliberately separate, because medical accuracy alone does not make a claim appropriate for advertising or public communication. A statement can be clinically correct and still overstate what a reader should take from it.

Version control and publication

Both approvals are recorded against the exact version of the content that was reviewed.

If the clinical wording is subsequently changed, the existing approvals no longer apply, and the page returns through the review process. Approval of an earlier version cannot be carried forward to a later one.

A page becomes publicly available and eligible for indexing only once the required approvals are in place and it has been published by an authorised administrator.

The review history is retained. Withdrawn or superseded approvals remain part of the governance record rather than being deleted, which gives a traceable history of how our clinical content has been reviewed over time.

Review cycle

Clinical content is reviewed whenever substantive clinical wording changes.

Every clinical page is also reviewed at least every 12 months, whether or not anything has changed.

Content may also be reviewed when there is a relevant change in clinical evidence, professional guidance, regulation, safety information, or in our own clinical policies and treatment protocols.

Each clinical page displays the date on which it was last clinically reviewed.

Clinical policies and protocols are themselves subject to periodic review through the wider clinical governance framework.

Raising a concern

If you have a concern about your care, or about anything published on this website, we want to hear about it.

Concerns can be raised with the clinical team directly, or by email to hello@healandgo.co.uk. Complaints are recorded, investigated, and responded to under our complaints procedure, and they feed into the governance review process described above.

Raising a concern will not affect the care you receive.

Clinical independence

Decisions about whether hyperbaric oxygen therapy is appropriate for a patient are clinical decisions, made by the hyperbaric medical team on clinical grounds.

Where treatment is not clinically appropriate, it is not offered, regardless of the patient's willingness to proceed privately.